ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Galvany Pharma Limited

Galvany Pharma Limited is an active company incorporated on 15 March 2022 with the registered office located in Stevenage, Hertfordshire. Galvany Pharma Limited was registered 3 years ago.
Status
Active
Active since incorporation
Company No
13977261
Private limited company
Age
3 years
Incorporated 15 March 2022
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Submitted
Dated 6 March 2025 (8 months ago)
Next confirmation dated 6 March 2026
Due by 20 March 2026 (4 months remaining)
Last change occurred 7 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (10 months remaining)
Address
Business & Technology Centre
Bessemer Drive
Stevenage
SG1 2DX
England
Address changed on 4 Aug 2022 (3 years ago)
Previous address was 3 Westfield Road Hertford England SG14 3DL England
Telephone
01438 310048
Email
Unreported
People
Officers
6
Shareholders
4
Controllers (PSC)
1
Director • Director • Chairman • British • Lives in England • Born in Jun 1966
Director • British • Lives in UK • Born in Jul 1969
Director • British • Lives in England • Born in Nov 1966
Director • British • Lives in England • Born in Mar 1976
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Galvany Developments Ltd
Cameron Robert Mitchell and Steven Charles Andrew Harris are mutual people.
Active
Fineve Ltd
Cameron Robert Mitchell is a mutual person.
Active
Albatrosstech Ltd
Steven Charles Andrew Harris is a mutual person.
Active
CS Pharmaceuticals Limited
Steven Charles Andrew Harris is a mutual person.
Active
Liveinoxford Ltd
Steven Charles Andrew Harris is a mutual person.
Active
Orama Therapeutics Ltd
Steven Charles Andrew Harris is a mutual person.
Active
Yakka Ltd
Steven Charles Andrew Harris is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2022–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£390.35K
Decreased by £288.08K (-42%)
Turnover
Unreported
Same as previous period
Employees
3
Increased by 3 (%)
Total Assets
£2.4M
Increased by £408.07K (+21%)
Total Liabilities
-£671.84K
Increased by £562.92K (+517%)
Net Assets
£1.72M
Decreased by £154.86K (-8%)
Debt Ratio (%)
28%
Increased by 22.56% (+412%)
Latest Activity
Full Accounts Submitted
1 Month Ago on 17 Sep 2025
Confirmation Submitted
7 Months Ago on 17 Mar 2025
Steven Charles Andrew Harris Details Changed
8 Months Ago on 1 Mar 2025
Mr Graham Robert Smith Details Changed
8 Months Ago on 1 Mar 2025
Own Shares Purchased
1 Year 2 Months Ago on 22 Aug 2024
Shares Cancelled
1 Year 3 Months Ago on 6 Aug 2024
Full Accounts Submitted
1 Year 7 Months Ago on 15 Apr 2024
Confirmation Submitted
1 Year 8 Months Ago on 6 Mar 2024
Christopher Blair Wagstaff Resigned
1 Year 9 Months Ago on 9 Feb 2024
Full Accounts Submitted
2 Years 2 Months Ago on 30 Aug 2023
Get Credit Report
Discover Galvany Pharma Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Total exemption full accounts made up to 31 December 2024
Submitted on 17 Sep 2025
Confirmation statement made on 6 March 2025 with updates
Submitted on 17 Mar 2025
Director's details changed for Steven Charles Andrew Harris on 1 March 2025
Submitted on 12 Mar 2025
Director's details changed for Mr Graham Robert Smith on 1 March 2025
Submitted on 11 Mar 2025
Resolutions
Submitted on 10 Mar 2025
Memorandum and Articles of Association
Submitted on 10 Mar 2025
Purchase of own shares.
Submitted on 22 Aug 2024
Cancellation of shares. Statement of capital on 25 July 2024
Submitted on 6 Aug 2024
Statement of capital following an allotment of shares on 25 July 2024
Submitted on 6 Aug 2024
Total exemption full accounts made up to 31 December 2023
Submitted on 15 Apr 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year